Tag Archives: health

Dr. M’s SPA Newsletter Volume 15 Issue 14

Podcast: Play in new window | Download

Subscribe: Email | RSS | More

As I have told many of my patients, I would write immediately when NC sees its first Measles case.

Well, North Carolina has its first measles case: The North Carolina Department of Health and Human Services has confirmed a case of measles in a child who was visiting Forsyth and Guilford counties. The child became ill while traveling to NC from another country where measles outbreaks have recently been reported. To protect the individual and their family’s privacy, no additional information about this individual will be released. This is the first confirmed case of measles in the state in 2025. NCDHHS is recommending all unvaccinated individuals ages one year and older receive measles vaccination to protect themselves and those around them. (NCDHHS)

So, it is finally in NC. If you are still on the fence of whether to vaccinate, the issue is now truly pressing.

From the CDC:

U.S. Hospitalizations in 2025

12% of cases hospitalized (148 of 1227)

Percent of Age Group Hospitalized

Under 5 years: 20% (72 of 355 cases) 50% of the total hospitalized. Highest risk bucket.

5-19 years: 8% (35 of 455)

20+ years: 10% (40 of 404)

Age unknown: 8% (1 of 13)

Deaths 3

And a story on Insurance Hell.

Enjoy,
Dr. M

Dr. M’s SPA Newsletter Volume 15 Issue 13

Podcast: Play in new window | Download

Subscribe: Email | RSS | More

Literature Review

1) An exciting phase three trial with the CETP inhibitor Obicetrapib has shown serious promise for ASCVD and Alzheimer’s Disease (AD). “In BROADWAY, a pre-specified AD sub-study was designed to assess plasma AD biomarkers in patients enrolled in the BROADWAY trial and evaluated the effects of longer duration of therapy (12 months) with a prespecified population of ApoE3/4 or 4/4 carriers. The sub-study included 1727 patients, including 367 ApoE4 carriers. The primary outcome measure was p-tau217 absolute and percent change over 12 months. Additional outcome measures included neurofilament light chain (“NFL”), glial fibrillary acidic protein (“GFAP”), p-tau181, and Aβ42/40 ratio absolute and percent change over 12 months. NewAmsterdam observed statistically significant lower absolute changes in p-tau217 compared to placebo over 12 months in both the full ITT population (p<0.002) and in ApoE4 carriers (p=0.0215).” (NAMS)

Obicetrapib has shown significant LDL and Lp(a) lowering effects as well in early trials. I will be watching this discovery closely as it may be a game changer for these diseases. “In the BROADWAY trial, more than 2,500 participants with established heart disease or genetic high cholesterol were given either Obicetrapib or a placebo, in addition to their regular cholesterol medications. After 12 weeks, those on Obicetrapib had dropped their LDL cholesterol by 32.6 per cent and Lp(a) by 33.5 per cent on average – many achieved guideline-recommended targets for the first time.” (Sci Tech Daily) The drop in Lp(a) is the profound result as this is a massive risk factor for ASCVD and to date is not moveable by statins and most used meds.

2) GLP1 drugs and risk for macular degeneration?… and more

Dr. M

Dr. M’s Women and Children First Podcast #92 – Kristin Jones, OT – A Therapists View of the World Today

\

Welcome back to Dr. M’s Women and Children First podcast where we look at the world of Women and Children’s Health through an anthropological lens with the humble understanding that we have a lot to learn.

Today, we’re honored to welcome Kristin Jones, a seasoned occupational therapist from Mooresville, North Carolina, whose career reflects both deep compassion and bold innovation in the service of neurodivergent children. Kristin brings 24 years of clinical and educational experience, including the past 14 spent working in a K-12 public charter school. Recently, she shifted gears in the most personal of ways—taking time away from school-based therapy to homeschool her daughter, who has Down Syndrome.

Kristin earned her Master of Occupational Therapy from Misericordia University in 2000 and has spent her career supporting children and families across a broad spectrum of settings from early intervention and outpatient sensory clinics to schools and feeding therapy. Her passion lies in translating complex concepts from brain development and the Autistic lived experience into practical, accessible strategies for educators.

In addition to her clinical work, Kristin is committed to the education of future therapists. She serves as adjunct faculty at Misericordia University and teaches with Education Resources Inc. Her presentations with the Therapist Neurodiversity Collective reflect her ongoing mission to uplift neurodivergent voices and move beyond outdated therapeutic norms.

Kristin’s voice is one of clarity and respect for children, for families, and for the evolving science of how we learn, communicate, and thrive.

Let’s dive in,

Dr. M

Podcast: Play in new window | Download

Subscribe: Email | RSS | More

Dr. M’s SPA Newsletter Volume 15 Issue 9

Podcast: Play in new window | Download

Subscribe: Email | RSS | More

Today, I’m diving into a fascinating article by Scott Zimmerman and Russel J. Reiter, titled Melatonin and the Optics of the Human Body, published in Melatonin Research (2019). This piece flips the script on what we thought we knew about melatonin, light, and how our bodies interact with the sun’s rays. It’s a game-changer, especially for how we think about kids’ health in our modern, screen-filled indoor living world.

First, what is melatonin? Melatonin is a hormone made from the essential amino acid, tryptophan. It was first isolated from a cow’s pineal gland. It is an old molecule as primitive bacteria made melatonin probably 2.5 billion years ago. Its synthesis in bacteria and eukaryotes is a common linkage. Most of us know that melatonin is the “sleep hormone,” produced by the pineal gland in the brain when it gets dark at night, signaling to our bodies that it’s time to wind down and prepare to sleep. It’s the chemical expression of darkness, driving our circadian rhythms and helping us catch those precious brain cleansing moments. Zimmerman and Reiter argue that this is only half the story or maybe even less than half. For decades, research has hyper-focused on pineal melatonin that is regulated by visible light hitting our retinas. Blue visible spectrum light in the early morning suppresses pineal melatonin, which is why we should dim those screens before bed. But here’s where it gets interesting, the pineal gland isn’t the only place melatonin is made, and darkness isn’t its only trigger. Our bodies are producing melatonin in ways we’re just starting to understand, and it’s tied to light in a way that was unexpected and evolutionarily fascinating. As with all things in science and evolution, we learn what we did not know and it all makes sense once the aha moment occurs…. and a literature review. Oh and a recipe.

Dr. M

Dr. M’s SPA Newsletter Volume 15 Issue 8

Podcast: Play in new window | Download

Subscribe: Email | RSS | More

Itaconate, what is it and why does it matter?

Science Heavy – skip to the bold for take home if you want to avoid the science.

The biggest takeaway from this complex science is this: High fat, high sugar diets (Ultra Processed Foods) are associated with decreased itaconate activity and increased inflammation. The science further answers the question of whether we should allow ultra processed food in schools.

Ultra Processed Foods likely reduce itaconate production driving inflammation, metabolic dysregulation, and gut dysbiosis, which could worsen active disease. Lower itaconate levels likely impair your body’s ability to resolve inflammation, potentially leading to prolonged issues with healing and repair. To support itaconate’s anti inflammatory activity, shift away from UPFs toward an anti-inflammatory diet (e.g., Mediterranean, rich in vegetables, omega-3s, and fiber) to reduce inflammation, support gut health, and enhance itaconate’s immune-regulating effects.

Science:…..

Enjoy,

Dr. M

Dr. M’s SPA Newsletter Volume 15 Issue 3

Podcast: Play in new window | Download

Subscribe: Email | RSS | More

Literature Review

1) Microplastics in the Brain – From Science Advances: “Human health is being threatened by environmental microplastic (MP) pollution. MPs were detected in the bloodstream and multiple tissues of humans, disrupting the regular physiological processes of organs. Nanoscale plastics can breach the blood-brain barrier, leading to neurotoxic effects. How MPs cause brain functional irregularities remains unclear. This work uses high-depth imaging techniques to investigate the MPs within the brain in vivo. We show that circulating MPs are phagocytosed and lead these cells to obstruction in the capillaries of the brain cortex. These blockages as thrombus formation cause reduced blood flow and neurological abnormalities in mice. Our data reveal a mechanism by which MPs disrupt tissue function indirectly through regulation of cell obstruction and interference with local blood circulation, rather than direct tissue penetration. This revelation offers a lens through which to comprehend the toxicological implications of MPs that invade the bloodstream.” (Huang et. al. 2025)

This weeks podcast is a direct look at the world of toxicology and the human consequences of exposure over time. Microplastics are the new and next trouble maker on the planet. This study raises the concern that micro and nano plastics can and do enter the brain and will disrupt and thus alter brain physiological processes. More time to answer the true risk reality. Not good. and more….Plus a letter about MAHA from Dr. Jeffrey Bland, a serious take on preventative medicine as opposed to disease pharmaceutical centric medicine.

Dr. M

Dr. M’s SPA Newsletter Volume 15 Issue 2

Podcast: Play in new window | Download

Subscribe: Email | RSS | More

Klotho Protein and Longevity

I am reposting this information from last year because it is going to stay on my mind and I would like everyone to be aware of this peptide and the future of healing and what we can do now to be healthy. The science here is one part fascinating, one part complicated and equal parts necessary.

Ok, it is time for a potential log step shift in the human understanding of neurological decline with age starting from birth.

Enter the peptide, (C)Klotho, named after the greek goddess of fate who spins the thread of life for all. The Klotho protein was discovered by researchers looking at mice that aged faster than the general mouse population. These mice were noted to have a shortened lifespan, stunted growth, renal disease, blood vessel calcification, cardiac hypertrophy, hypertension, pulmonary disease, cognitive impairment, multi-organ atrophy and fibrosis. (Prud’homme et. al. 2022) When they looked closer, these mice were found to have hypoactive klotho proteins leading to an explosion of research over the past two decades to understand why. The next question was, could the hyperactive state provide an anti aging effect? To be clear the word anti aging should really say delayed inevitable aging.

The answer was a resounding yes!…..

Dr. M

1 2 … 22